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Abstract
Background: It has been accepted that HIV buds from the cell surface in T lymphocytes, whereas
in macrophages it buds into intracellular endosomes. Recent studies, on the other hand, suggest
that HIV preferentially buds from the cell surface even in monocytic cells. However, most studies
are based on observations in acutely infected cells and little is known about HIV budding
concomitant with reactivation from latency. Such studies would provide a better understanding of
a reservoir for HIV.
Results: We observed HIV budding in latently infected T lymphocytic and monocytic cell lines
following TNF-α stimulation and examined the upregulation of host factors that may be involved
in particle production. Electron microscopy analysis revealed that reactivation of latently infected
J1.1 cells (latently infected Jurkat cells with HIV-1) and U1 cells (latently infected U937 cells with
HIV-1) displayed HIV particle budding predominantly at the plasma membrane, a morphology that
is similar to particle budding in acutely infected Jurkat and U937 cells. When mRNA expression
levels were quantified by qRT-PCR, we found that particle production from reactivated J1.1 and U1
cells was accompanied by CD44 upregulation. This upregulation was similarly observed when
Jurkat and U937 cells were acutely infected with HIV-1 but not when just stimulated with TNF-α,
suggesting that CD44 upregulation was linked with HIV production but not with cell stimulation.
The molecules in endocytic pathways such as CD63 and HRS were also upregulated when U1 cells
were reactivated and U937 cells were acutely infected with HIV-1. Confocal microscopy revealed
that these upregulated host molecules were recruited to and accumulated at the sites where
mature particles were formed at the plasma membrane.
Conclusion: Our study indicates that HIV particles are budded at the plasma membrane upon
reactivation from latency, a morphology that is similar to particle budding in acute infection. Our
data also suggest that HIV expression may lead to the upregulation of certain host cell molecules
that are recruited to sites of particle assembly, possibly coordinating particle production.
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It has been thought that HIV particles assemble and bud
at the plasma membrane (PM) in T lymphocytes and
HeLa cells, but at the endosomes in macrophages, suggest-
ing that such endosomal targeting may be essential for
HIV budding in macrophages [1-6]. However, recent stud-
ies using the inhibitors of the endocytic pathway and
membrane-impermeant dyes have revealed that the PM is
the primary site for HIV assembly and particle budding
even in macrophages and that particles accumulate at the
endosomes through endocytosis [7-9]. Nevertheless,
these studies are based on observations in acutely infected
cells and little is known about HIV budding concomitant
with reactivation from latency. Latently infected resting T
cells are known to serve as a stable reservoir for HIV dur-
ing anti-retroviral therapy and to produce infectious parti-
cles upon cell reactivation. Studies on HIV production
from latently infected cells upon reactivation are neces-
sary for a better understanding of HIV pathogenesis,
although some studies have indicated intracellular accu-
mulation of particles in chronically or latently infected
cells [10,11]. Here, we employed J1.1 cells that were Jur-
kat T lymphocytic cells latently infected with HIV-1, and
U1 cells that were U937 monocytic cells latently infected
with HIV-1, and observed HIV particle budding following
reactivation.
We initially tested the dose of TNF-α, and temporally
monitored cell growth and HIV particle production after
stimulation (Fig. 1A). J1.1 cells proliferated equally
regardless of the dose of TNF-α, and the particle produc-
tion levels increased to 50 ng/ml TNF-α. In contrast, pro-
liferation of U1 cells was inhibited in a dose-dependent
manner, and the highest level of particle production was
observed at 50 ng/ml. We thus used 50 ng/ml TNF-α for
further experiments. To avoid nonspecific stimulation by
changing the medium, we added TNF-α directly to the cul-
ture medium, and this led to the higher dose of TNF-α
required in our study than in other reports [12,13].
Electron microscopy was carried out to examine where
particle budding occurred in J1.1 and U1 cells upon reac-
tivation (Fig. 1B). Little or no particles were produced in
either cell line before TNF-α stimulation (Fig. 1B, most
left panels), consistent with previous reports [11-14].
Upon stimulation, nascent budding particles were visible
on the surface of nearly all J1.1 cells, similar to the case
with U1 cells (Fig. 1B, arrowheads). Unexpectedly, parti-
cles in intracellular vesicles were rarely seen in both J1.1
and U1 cells (Fig. 1B, arrow). The findings were confirmed
by immunoelectric microscopy using anti-HIV-1 p17MA
antibody (Fig. 1B, most right panels). Next, their parental
cell lines, Jurkat and U937 cells, were infected with HIV-1,
and particle production in acute infection were examined
by electron microscopy. Particle budding was observed
predominantly at the PM of both Jurkat and U937 cells
(Fig. 1C, arrowheads) but some U937 cells displayed bud-
ding into intracellular compartments (Fig. 1C, arrows).
Immunoelectric microscopy indicated similar results (Fig.
1C, most right panels). For quantification, we counted the
number of cells containing particles at the PM alone or
that of cells containing particles at both intracellular vesi-
cles and the PM (Fig. 1D). Budding at the PM was promi-
nent, regardless of whether cells were acutely or latently
infected, or T lymphocytic or monocytic, suggesting that
unlike chronically infected cells [10], HIV particles are
most likely budded from the PM in latently infected cells,
although it cannot be ruled out in this experiment that the
particles observed in extracellular spaces might be
released by exocytosis.
Gene expression analysis based on cDNA microarrays has
extensively been employed and has provided evidence for
the modulation of host cellular gene expression upon HIV
infection (replication and latency) [15-20]. Although
numerous host genes are modulated upon HIV infection,
it is conceivable that expression levels of host membrane
components may change by feedback regulation upon
HIV reactivation, as HIV requires host cell membrane for
particle budding. A membrane contains a number of
microdomains, enriched in cholesterol (i.e., rafts) and in
tetraspanins (e.g., CD63 and CD81), which accumulate at
sites of HIV budding [7,21-26]. It has been shown that
TSG101, a component of endosomal sorting complex
required for transport (ESCRT) is recruited to the sites of
particle assembly and is responsible for HIV particle bud-
ding [27,28]. Thus we chose endosomal (EEA1, CD63,
HRS, TSG101, and Syntaxin12) and PM (CD44 and
SNAP23) markers and quantified their mRNA levels by
qRT-PCR (Fig. 2A and 2B) using the primer sets shown in
Additional File 1. Their properties and functions are as fol-
lows: EEA1 is a marker molecule for early endosome; HRS
is an initial molecule for the ESCRT pathway; Syntaxin12
is a SNARE molecule for endosomal membrane fusion;
CD44 is an adhesion molecule implicated in cell migra-
tion; SNAP23 is a SNARE molecule for PM fusion in the
exocytic pathway. When the mRNA levels in J1.1 cells
stimulated with TNF-α were compared with those in
unstimulated J1.1 cells, CD44 gene expression was
increased, but the other genes tested were largely unal-
tered. No significant upregulation of CD44 was observed
when cells of its uninfected parental line, Jurkat, were sim-
ilarly stimulated with TNF-α, indicating that the CD44
upregulation was not simply due to cell stimulation (Fig.
2A, upper). CD44 has been reported hardly expressed
even at mRNA level in unstimulated Jurkat cells [29]. A
similar analysis was carried out for U1 cells. Downregula-
tion of CD44 has been reported for chronically infected
monocytic cells [30]. Upon reactivation, CD44 upregula-
tion was apparent but the endocytic molecules (CD63Page 2 of 7
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Reactivation of latently infected J1.1 and U1 cells displays HIV particle budding at the PMFigure 1
Reactivation of latently infected J1.1 and U1 cells displays HIV particle budding at the PM. (A) HIV production 
from J1.1 and U1 cells upon TNF-α stimulation. J1.1 and U1 cells were stimulated with TNF-α (~100 ng/ml). Levels of particle 
production were measured by p24 antigen ELISA. (B) HIV particle budding from J1.1 and U1 cells upon TNF-α stimulation. J1.1 
and U1 cells stimulated with 50 ng/ml TNF-α were subjected to conventional electron microscopy and immunoelectric micro-
scopy using anti-HIV-1 p17MA antibody. (C) HIV particle budding from acutely infected Jurkat and U937 cells. Jurkat and U937 
cells were infected with HIV-1 (LAV strain) corresponding to 100–200 ng of p24CA antigen and were analyzed by electron 
microscopy. Arrowheads indicate budding particles and arrows indicate particles into intracellular vesicles in (B) and (C). (D) 
Semi-quantification of HIV-1 particle localization. Approximately 300 of particle-positive cells observed by conventional elec-
tron microscopy were sorted into the categories indicated.
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The modulation of others such as TSG101 was not statis-
tically significant. These upregulations were not observed
when uninfected U937 cells were stimulated (Fig. 2A,
lower). The gene expression profiles upon reactivation
were consistent with protein expression levels of the mol-
ecules when analyzed by Western blotting (Fig. 2C). We
cannot simply compare the data of J1.1 and U1 cells, since
expression levels of individual genes differ between the
cell lines, but these significant upregulations were not
observed in their parental but uninfected cells, suggesting
that the upregulations might be linked with HIV expres-
sion. To test this possibility, we quantified expression lev-
els of the same genes in acutely infected Jurkat and U937
cells and compared them with the levels in uninfected Jur-
kat and U937 cells. Upregulation of CD44 was observed
in acutely infected Jurkat cells (Fig. 2B, upper), and this
magnitude fold of upregulation was likely due to a very
low level of CD44 expression in uninfected Jurkat cells
[29]. In acutely infected U937 cells, besides CD44 upreg-
ulation, upregulation of other genes (CD63, HRS, and
SNAP23) was observed (Fig. 2B, lower). Together, the
results indicate that the upregulation of host molecules
observed here was likely to be linked with HIV produc-
tion. Higher levels of gag mRNA than tat mRNA observed
in this study were possibly because we analyzed at a late
stage of HIV replication. Western blotting confirmed HIV
antigens, p55Gag precursor and its processing products,
p24CA and p17MA, appeared upon reactivation or infec-
tion and showed that unlike anti-p24CA antibody, anti-
p17MA antibody used in this study (against the C-termi-
nal region of p17MA) recognized the mature p17MA
domain but not the unprocessed p55Gag (Fig. 2C).
Confocal microscopy revealed that the anti-p17MA anti-
body specifically detected mature p17MA produced upon
HIV protease-mediated Gag processing (Fig. 3A). Since
Gag processing occurs concomitant with particle budding,
the p17MA signal obtained with the antibody most likely
represents the sites of particle budding [4,31]. No p17MA
signal was seen on the day after infection, indicating that
it was not derived from residual HIV (Fig. 3A). When J1.1
and U1 cells were reactivated, the p17MA antigens were
observed at the cell periphery, likely at the PM, but no sig-
nals were seen in unstimulated cells (Fig. 3B). Similarly,
the p17MA antigens were observed at the PM in acutely
infected Jurkat and U937 cells (Fig. 3C). For quantifica-
tion, we counted the numbers of cells based on p17MA
distribution patterns (PM, intracellular+PM, or negative)
and confirmed that HIV particles were preferentially
formed at the PM (Fig. 3D), consistent with the data
obtained by electron microscopy (Fig. 1D).
To understand the significance of the upregulation of host
molecules observed here, we examined intracellular local-
ization of the molecules by immunostaining. No CD44
staining was found in unstimulated J1.1 and U1 cells,
consistent with previous reports indicating CD44 down-
regulation during latency [30,32]. Following reactivation,
CD44 was visible and colocalized with the p17MA anti-
gens at the PM. Similarly, CD63 and HRS stainings were
rarely seen in unstimulated cells but became visible and
colocalized with the 17MA signals, especially in U1 cells
(Fig. 3B). These findings were very apparent in acutely
infected cells (Fig. 3C): CD63 recruitment, as reported
previously for acutely infected Jurkat T cells and macro-
phages [7,25,33,34], and HRS and CD44 accumulations
to the sites where mature particles were formed. Together,
our data suggest that HIV expression may lead to the
upregulation of certain host molecules that are recruited
to the sites of particle assembly, possibly to coordinate
particle production. Because CD44 is a cell adhesion mol-
ecule that mediates lymphocyte aggregation and homing
[35,36], it is conceivable that the CD44 recruitment to
HIV assembly sites may lead to an efficient cell-to-cell
transmission of HIV and infected cell migration to lymph
nodes.
In conclusion, despite numerous literature on HIV bud-
ding to intracellular compartments especially in macro-
phages, our data indicate that upon reactivation from
latent infection, HIV predominantly buds at the PM, a
HIV particle production is accompanied by mRNA upregulation of CD44 and endocytic moleculesFigure 2 (see previous page)
HIV particle production is accompanied by mRNA upregulation of CD44 and endocytic molecules. (A) Differen-
tial gene expression upon reactivation. J1.1 and U1 cells were either unstimulated or stimulated with 50 ng/ml TNF-α (gray col-
umns). For comparison, uninfected Jurkat and U937 cells were similarly stimulated (white columns). Expression of each gene 
was quantified by qRT-PCR and normalized to the level of GAPDH. The fold increase of expression of each gene upon stimu-
lation was shown. *, p < 0.01; **, p < 0.05. Expression levels of HIV-1 gag and tat mRNAs were quantified using specific primers 
(HIV-1 nucleotide positions 701–720 and 787–806 for gag and 5965–5987 and 8389–8411 for tat, respectively) (black col-
umns). (B) Differential gene expression upon acute infection. Jurkat and U937 cells were infected with HIV-1 and subjected to 
qRT-PCR. The fold increase of each gene expression upon infection was shown (gray columns). *, p < 0.01; **, p < 0.05. (C) 
Protein expression of J1.1, U1, Jurkat, and U937 cells. TNF-α stimulation and infection were similarly performed. Cells were 
subjected to Western blotting using anti-CD44, anti-CD63, anti-HRS, anti-actin, anti-HIV-1 p17MA, and anti-p24CA antibod-
ies.Page 5 of 7
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infection, suggesting that HIV latency have a potential for
robust production of HIV observed for acute infection.
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Upregulated molecules are accumulated to sites of HIV-1 particle buddingFigure 3
Upregulated molecules are accumulated to sites of HIV-1 particle budding. (A) Inhibition of Gag processing in J1.1 
cells stimulated but treated with 1 μM ritonavir (upper) and residual HIV in Jurkat cells after infection (lower). For confocal 
microscopy, the cells were stained with anti-HIV-1 p17MA (green), p24CA (red) antibodies and with TOPRO-3 (blue). (B) 
Intracellular localization of upregulated molecules upon reactivation. J1.1 and U1 cells were either unstimulated (Unsti.) or 
stimulated (Sti.) with TNF-α and were immunostained with anti-p17MA antibody (green) and antibodies for CD44, CD63, and 
HRS (red). (C) Intracellular localization of upregulated molecules upon acute infection. Jurkat and U937 cells were infected 
with HIV-1 and immunostained. Inf., infected; Uninf., uninfected. (D) Semi-quantification of sites for HIV-1 particle production. 
Examples of cells exhibiting PM staining alone, intracellular+PM accumulations, and no signals (negative) (upper). Based on 
p17MA localization (PM, intracellular+PM, or negative), approximately 100–150 cells were sorted into the categories (lower).Page 6 of 7
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